Paul Colussi

Paul is TetraGenetics’ Vice President, Research. Before joining the TetraGenetics team he was involved in expression platform development at New England Biolabs for seven years culminating in the release of the commercially available K. lactis yeast expression kit. Currently, he oversees TetraGenetics’ drug discovery pipeline as well as projects for both corporate and government clients. He obtained his BSc (Hons) from the University of Sydney and his PhD from the Biochemistry Department at the University of Illinois.